T HYROGLOBULIN (Tg) (1) is the major secretory product of thyroid epithelial cells. In a complex bidirectional pathway, Tg is transported to the apical plasma membrane, secreted into the lumen of thyroid follicles, and finally reinternalized by the epithelial cells (2-4). The follicular lumen, surrounded by a tight monolayer of thyrocytes, represents an extracellular compartment where Tg is stored at high concentrations of up to 400 mg/ ml (5,6). It is generally accepted that thyroid hormone liberation from Tg occurs separately from this storage compartment within the lysosomes (2, 4, 7-10). Several groups, however, studying the degradation of Tg were unable to detect thyroid hormones in lysosomal fractions from thyroid epithelial cells (ll-13), which was explained to result from the rapid export of triiodo-L-thyronine (T3) and L-T~ (TJ from the lysosomal vesicles. Furthermore, luminal Tg occurs in a soluble or covalently cross-linked form (14). Because cross-linked Tg can fill the entire follicle lumen, thereby forming globules of diameters of 20-120 pm, an extracellular solubilization process before endocytosis of Tg by thyroid epithelial cells has been postulated (14) . The solubilization process may be required not only for endocytosis of Tg from globules but also for that from smaller Tg aggregates that, nevertheless, are too big to be internalized. Macropinocytosis, a thyroid-specific form of phagocytosis mediated by pseudopods, has been described previously (15) and could be a mechanism to solve this problem.
Most observations, however, indicate that selective pinocytosis of soluble Tg molecules is the major pathway of Tg entry into thyroid epithelial cells (8, 16, 17), strongly arguing for a solubilization process before endocytosis of Tg. As thyroid hormone liberation from Tg is a fast process, occurring within minutes (7, 18), it was suggested that degradation of Tg may start in an early endocytic compartment, such as the endosome (11, 12, 19, 20) , or in the lumen of thyroid follicles (13 Media, i.c,. secretory products of thyrocytes, were collccted from the cells, cleared by centrifugation (twice for 10 min, 150 x g, 4 C), and concentrated by ultrafiltration (Centricon-10). Cells were washed three times with ice-cold PBS, then harvested using rubber policemen.
Cell suspensions were pelleted and washed three times by centrifugation (10 min, 150 X s) at 4 C. The pellets were resuspended in 100 mM Sorensen phosphate buffer (KH,PO, and NaH,PO,, pH 7.2), supplemented with 0.25 M sucrose and 5 mM EDTA, and homogenized on ice using a Dounce homogenizer (Kontes Co., Vineland, NJ). Cellular debris and nuclei were removed from cell homogenates by centrifugation (5 min, 900 X ,y, 4 C). Lysosomes were enriched by centrifugation at 10,000 x s for 10 min at 4 C. The resulting pellet was resuspended in Sorensen phosphate buffer (pH 5.0) supplemented with 0.2% Triton X-100 and further incubated for 30 min on ice. The supernatant of the final centrifugation step (10 mm, 15,000 X s, 4 C) was then used as isolated lysosomal enzymes for the irr 7utro incubation assays. Plasma membrane vesicles were prepared according to the methods of Hubbard iat nl. (30) and Bauvois rf al. (31) with minor modifications.
The supernatant (0.5 ml) of the 10,000 X s centrifugation step was layered on top of 1 ml 1.2 M sucrose-5 mM EDTA in 0.1 M Sorensen phosphate buffer (pH 7.2) and 3.5 ml 0.32 M sucrose-5 rnM EDTA in 0.1 M Sorensen phosphate buffer (pH 7.2) and centrifuged for 2 h at 100,000 X s at 4 C. The resulting band at the interphase between 0.32 and 1.2 M sucrose was carefully removed with a syringe and resuspended in 10 ml PBS. Plasma membrane vesicles were collected as the pellet of the following centrifugation (1 h, 100,000 X s, 4 C) and lysed in PBS (pH 7.2), as described for lysosomes.
For and thus resembled the cellular location of APN. In addition, the perinuclear region of epithelial cells was immunostained (Fig. lb, nrrozu) . However, when cells were labeled with monoclonal antibodies against mature cathepsin B, cytoplasmic vesicles of various sizes were visible in immunofluorescence (Fig. lc) . These vesicles were numerous in the perinuclear region of the cells and thus resembled lysosomes (Fig. lc, mmzus) . Furthermore, 300-nm cryosections through thyroid epithelial cells were stained with monoclonal antibodies against mature cathepsin B and analyzed by electron microscopy.
In such sections, the apical plasma membrane of the epithelial cells was identified by the APN (a; APN) , procathepsin L (b; ProCL), or mature cathepsin B (c; mCB) after fixation with 8% formaldehyde. The ectoprotease APN was localized to the cell surface, which was visible by the punctated staining that was prominent at the borders between presence of numerous microvilli (Fig. 2a) . Although cathepsin B was not visible at the plasma membrane when using light microscopical techniques (Fig. lc) , higher resolving cryoelectron microscopy revealed the presence of the protease at the apical cell surface of thyroid epithelial cells (Fig.  2, a and b) . The numbers of gold particles per pm2 were determined to quantitate the relative amounts of cathepsin B immunolabeled at various cellular sites. Cathepsin B labeling within the endosomal/lysosomal system was highest with 68%; however, labeling at the plasma membrane was well above background and amounted to 27% of the total immunolabeled cathepsin B (Fig. 2~) .
To further analyze the molecular forms of released cathepsins B and L, lysates and conditioned media of thyrocytes were probed for the presence of the proteases. In the case of cathepsin L, monolayer thyrocytes were biosynthetically labeled with [35S]methionine and [35S]cysteine overnight. The cell lysates and media were subjected to immunoprecipitation with antibodies against cathepsin L (Fig. 3a) . SDS-PAGE and subsequent fluorography of the immunoprecipitates revealed the presence of the majority of procathepsin L in the conditioned medium of thyrocytes (Fig. 3a, SEC) . From cell lysates, the pro form and the mature single and two chain forms of cathepsin L were immunoprecipitated (Fig. 3a,  cells) . When comparing the cellular signal of cathepsin L to that observed in the medium, one can deduce that a major portion of newly synthesized procathepsin L is released from thyroid epithelial cells. Whereas immunoprecipitation of porcine cathepsin B was not possible with a variety of antibodies tested, the monoclonal antibody proved to be useful for immunoblotting. Therefore, conditioned media of thyrocytes were concentrated 20-fold by ultrafiltration, and together with cell lysates, these samples were analyzed by SDS-PAGE and Western blotting. Probing the Western blots with monoclonal antibodies against mature cathepsin B revealed the presence of the pro and mature forms of cathepsin B in lysates from thyroid epithelial cells (Fig. 3b, cells) . Most important, the cells released both forms of the cathepsin, as both pro-and mature cathepsin B were recognized in the secretions of the cells (Fig. 3b, SEC) . Further evidence for the extracellular presence of mature cathepsin B comes from experiments with human thyrocytes labeled with [lz51]NaI in which the mature form of cathepsin B was immunoprecipitated from cell lysates as an iodinated protein (Fig. 3c, cells) . Thyrocytes are able to iodinate proteins that come into con tact with thyroid peroxidase (32). As this iodination process was shown to be executed on the apical plasma membrane of the cells, the results suggested the presence of mature cathepsin B at the cell surface of thyroid epithelial cells.
Released cathepsin B is proteolytically active in the extracellular space and at the plasma membrane of thyrocytes These results showed that the release of procathepsin L The proteolytic activity of cathepsin B was analyzed by and procathepsin B was accompanied by the release of a cytochemical means. Vital or formaldehyde-fixed thyrocytes small fraction of mature cathepsin B. Furthermore, iodinaon coverglasses were incubated at pH 6.2 or pH 7.2 with the tion of mature cathepsin B provides evidence for its transport cathepsin B-specific substrate Z-Arg-Arg-4MPNA in the to and association with the apical plasma membrane of thypresence of NSA as the precipitating agent for proteolytically rocytes.
released 4MPNA. The reaction product was then made vis- ible by fluorescence microscopy. Vital cells reacted with the substrate at pH 6.2 showed a fluorescence staining mainly at the borders between neighboring cells of a monolayer and, thus, at the plasma membrane (Fig. 4a, arrowheads) . However, when formaldehyde-fixed cells were reacted at pH 6.2, the fluorescence staining was predominantly associated with cytoplasmic vesicles, namely lysosomes, surrounding the nuclei (Fig. 4b, UYYOWS) . The reaction product was also detected in close association with the plasma membrane of thyrocytes or in extracellular spaces of nonconfluent monolayers (Fig.  4b, arrowhead) . Similar, but weaker, signals were obtained when glutaraldehyde-fixed cells were used (not shown). When cells were reacted with the substrate at pH 7.2, the fluorescent signal was weaker than that at pH 6.2, but the same localization was observed (not shown). Most important, the cleavage of Z-Arg-Arg-4MPNA
was completely abolished when thyrocytes were preincubated with E64 to irreversibly inhibit the proteolytic activity of cathepsin B (not shown).
The extracellular proteolytic activity of cathepsin B at pH 7.2 was further analyzed in electron microscopical studies. Thyroid epithelial cells were fixed with 0.5% glutaraldehyde and reacted with the substrate Z-Arg-Arg-4MPNA, and the cleavage product was precipitated by HPR before postfixation in 2.5% glutaraldehyde and embedding in Epon. The reaction product, detectable because of its higher contrast due to osmification, was seen within lysosomes (Fig. 5a , arrow) and was most prominent at the surface of the cells ( Fig.  5a ; the cell is completely surrounded by reaction product), suggesting proteolytically active cathepsin B at the plasma membrane of thyrocytes. Such extensive reaction products were, however, only seen in about 20% of the cells. To ensure that the reaction was indeed due to cathepsin B present at the cell surface of thyroid epithelial cells, colocalization of the protein with the reaction product was performed by postembedding immunolabeling of sections from reacted cells (Fig.  5b) . Cathepsin B was immunolocalized within or associated with ER profiles (Fig. 5b, arrows) and was absent from mitochondria, cytoplasmic matrix, and nuclei. For the specificity of cathepsin B labeling, refer to Fig. 2c . Most important, cathepsin B was immunolocalized to regions of highest contrast, i.e. the cell surface, indicating the close association of the protein with the plasma membrane of thyrocytes (Fig. 5b,   arrowheads ).
From these results we concluded that cathcpsin B was proteolytically active in extracellular locations of thyroid epithelial cells, i.e. in the surrounding medium and at the plasma membrane. Most important, proteolytic activity was retained at neutral pH conditions and was completely abolished by E64, an irreversible inhibitor of cysteine proteases.
Extracellular
proteolysis of Tg leads to the rapid liberation of T4
As the thyroid hormones T, and T, are liberated from the prohormone Tg by proteolysis and because Tg is the major secretory product of thyroid epithelial cells, we envisioned a function for the released procathepsin L and the mature cathepsin B in extracellular proteolysis of Tg before endocytosis and delivery of the protein to lysosomes. Therefore, the possibility of extracellular proteolysis was tested by monitoring the liberation of thyroid hormones from Tg and measuring the degradation of the Tg polypeptide mediated by secreted or plasma membrane-associated proteases and was compared to lysosomal proteolysis.
The media of cultured epithelial cells were concentrated, and plasma membranes or lysosomes were isolated by sucrose density centrifugation. The purity of the plasma membrane preparation was proven by electron microscopy (Fig.  6 ) and the presence of APN and its activity (not shown). Lysosomal preparations were analyzed by SDS-PAGE and Western blotting and were shown to contain high amounts of mature cathepsins B and D, as expected (not shown). Such preparations with or without cysteine reactivation (see Materials and Methods) were then incubated with Tg for 30 min at 37 C. Incubations of secreted or plasma membraneassociated proteases with Tg were performed at pH 7.2, whereas lysosomal proteases were reacted with Tg at pH 5.0. The reaction was stopped by the addition of protease inhibitors and potassium iodide to block deiodination. In 0 min controls, the subcellular fractions were reacted with the protease inhibitors and potassium iodide before the addition of Tg. Values of 0 min controls were subtracted from 30 min values to show the potency of each subcellular fraction to rapidly liberate thyroid hormones.
When cysteine proteases were not reactivated, thyroid hormones were predominantly liberated by lysosomal proteases (Fig. 7, a and c) . The contribution of extracellular proteolysis to thyroid hormone liberation ranged from 6-33% (Fig. 7, a and c) , indicating that thyroid hormone liberation from Tg is not limited to lysosomal proteolysis. The amounts of liberated thyroid hormones within the 30-min incubation period were enhanced when cysteine proteases were reactivated (Fig. 7, b and d) . Most important, the liberation of T, by extracellular means increased from 6% to 54% of the total T4 liberation upon reactivation of cysteine proteases (Fig. 7, a and b) . In contrast, lysosomal proteases incubated with Tg at pH 5.0 were most efficient in the liberation of T3 (Fig. 7, c and d) .
The results demonstrated that the potency to liberate thyroid hormones from Tg was not limited to lysosomal proteolysis. Rather, extracellularly acting proteases liberated T, as efficiently as lysosomal proteases. The reactivation experiments suggested an involvement of cysteine proteases in this process. As the cysteine proteases cathepsins B and L were detected in the extracellular space of thyrocytes, we propose them to function in extracellular T, liberation. The degradation status of Tg at steady state was analyzed by SDS-PAGE and immunoblotting with anti-Tg antibodies of the various subcellular fractions, namely secretory products, plasma membranes, and lysosomes. Tg is a glycoprotein with a molecular mass of 330 kDa which migrates as a double band in SDS-gels (Fig. 8a, PBS, Tg monomer) . The secretory products of thyrocytes contained Tg in a form indistinguishable from the Tg standard in SDS-PAGE analysis (Fig. 8a , compare SEC with PBS). However, in plasma membrane preparations, monomeric Tg was detected together with high mol wt degradation fragments (Fig. 8a, PM) . Within lysosomes, intact monomeric Tg was absent, whereas one degradation fragment of approximately 25 kDa was highly en- riched (Fig. 8a, LYS) . These results indicated that lysosomal proteolysis of the Tg polypeptide exceeded that of extracellular proteolysis under steady state conditions. However, extracellular proteolysis was implicated from the potency of secreted or plasma membrane-associated proteases to liberate thyroid hormones from Tg (c$ Fig. 7) .
Therefore, we analyzed the degradation of the Tg polypep- The three subcellular fractions were incubated with enzymatically iodinated Tg for 30 min at 37 C (Fig. Bb, 30 min) and under the corresponding pH conditions, i.e. pH 7.2 for secretory products or plasma membranes and pH 5.0 for lysosomes. Zero time control incubations were reacted with protease inhibitors before the addition of iodinated Tg (Fig. 8b, 0 min) . These preparations were then analyzed by autoradiography after SDS-PAGE (Fig. 8b) . The amounts of monomeric Tg were densitometrically determined. The results indicated that the polypeptide chain of Tg appeared unchanged in SDS-PAGE after incubation with secretory products (Fig. 8b, SEC) or plasma membraneassociated proteases (Fig. 8b, PM) for 30 min at 37 C. However, 45% of monomeric Tg was degraded by lysosomal proteases during the 30-min incubation period, which resulted in the formation of various degradation fragments (Fig. 8b, LYS, arrowheads) . The degradation fragments originated from Tg, as scanning of the LPO band revealed no degradation of this self-iodinated protein. Similar results were obtained when nonenzymatically iodinated Tg or nonradioactive Tg was used (not shown).
Because the thyroid hormones T, and T, are formed close to the N-and C-terminals of Tg, these results suggested that extracellular liberation of thyroid hormones from Tg occurred by selective, but limited, proteolysis in addition to lysosomal proteolysis, which leads to complete degradation of the Tg polypeptide. Proteolysis of Tg is the prerequisite for the liberation of thyroid hormones and the complete degradation of the molecule and is considered to be limited to the lysosomes after Tg has followed the secretion, storage, and recapture pathway in thyrocytes. However, proteolysis could, in principle, occur in ail compartments along this transport pathway, including the apical cell surface. Here, we report on the release of procathepsins B and L and proteolytically active mature cathepsin B from thyroid epithelial cells in culture. Our results suggest that thyroid hormone liberation is not restricted to lysosomes, but is, as far as the liberation of T, is concerned, equally mediated by extracellularly acting proteases. The liberation of T, and final degradation of the Tg polypeptide occur mainly intracellularly by lysosomal degradation. for involvement of cathepsins in extracellular proteolysis of Tg, which results in the rapid liberation of T4, are 1) that they are proteolytically active at neutral pH; and 2) that they are able to cleave Tg.
In vitro studies have shown previously that thyroid hormone liberation from Tg is a complex process, which requires synergism among various proteases proteolysis at the cell surface is only possible if the involved proteases are proteolytically active at neutral pH. The pH optimum for cathepsin L is approximately 5.0-6.5. However, cathepsin L has a residual proteolytic activity of 30-40% at neutral pH (24, 25). Furthermore, procathepsin L has been shown to be a proteolytically active form of the enzyme stabilized by the propeptide at neutral pH in some cellular systems (49,50). Thus, an involvement of procathepsin L in extracellular Tg degradation was envisioned; however, direct evidence for the proteolytic activity of procathepsin L in the extracellular environment of thyrocytes is lacking. Cathepsin B has a pH optimum of approximately 6.0 for most substrates (24, 25). It is believed that cathepsin B is irreversibly inactivated above pH 7.0 (25), with a half-life of about 7 min at pH 7.5 (51). In contrast, it was shown recently that cathepsin B from human liver cleaves collagen IV, laminin, and fibronectin at pH 7.4 (35). In addition, when using Z-Arg-Arg-paranitroanilide as a substrate for bovine kidney cathepsin B,, a residual activity of 46% was determined at pH 7.0, which declined to 21% at pH 7.4 compared to 100% at pH 6.0 (Brix, K., unpublished observations).
Here, we have demonstrated that a fraction of mature cathepsin B is released from porcine thyrocytes. Most important, cathepsin B was shown to be proteolytitally active at the cell surface of porcine thyrocytes at neutral pH. 
